Search results
The Art of Stock-Picking: Joel Tillinghast's guide to long-term investment success - How to achieve...
The Economic Times· 3 hours agoLegendary fund manager Joel Tillinghast advises equity investors to achieve long-term success by...
LIC share at record high; m-cap hits Rs 7.56 trn post 39% rally in CY24
Business Standard India· 1 day agoLIC Share Price: With today's gain, LIC's market capitalisation (m-cap) reached an all-time high of...
Stock market update: Power stocks up as market falls
The Economic Times· 2 days agoThe 30-share BSE Sensex closed down 109.08 points at 80039.8
Work’s Next Revolution: Forging a Talent Ecosystem for the Gen AI Age - ETHRWorld
The Economic Times· 2 days agoAccenture in India in collaboration with ETHRWorld organized a roundtable on "Workforce of the...
Stock Market Live: Nifty, Sensex Extend Losses To Fifth Day As Axis Bank, RIL Drag
NDTV Profit· 2 days agoAt pre-open, the NSE Nifty 50 was 182.55 points or 0.75% lower at 24,230.95, and the S&P BSE Sensex...
Mid-day Mood| Sensex, Nifty slip further as banks, FMCG stocks fall
CNBC Awaaz· 3 days agoTata Consumer Products, Bajaj Finance, Bajaj Finserv, Nestle India, Axis Bank were the top losers on...
Indian Bank Summary: Latest Updates and Details | India Infoline
India Infoline· 3 days agoA premier bank owned by the Government of India, the Indian Bank was incorporated in 05 March 1907 as Indian Bank Limited and commenced operations in 15 August 1907 as part of the Swadeshi Movement ...
Trade setup for Wednesday: Top 15 things to know before the opening bell
CNBC Awaaz· 4 days agoExperts expect the Nifty 50 to resume its upward journey soon towards 24,850 as long as it holds the...
Union Budget 2024 promises a paid internship scheme for the youth: What is it all about?
Hindustan Times· 4 days ago...the hustle-bustle and inner workings of India's “top 500 companies” makes it possible for the...
Cost control: drug pricing policies around the world
Pharmaceutical Technology· 4 days agoDespite sustained scrutiny on the cost of medicines across the globe, there is little consensus on the optimal balance between protecting industry...